Mika Kuwahara

3PUBLICATIONS
13CO-AUTHORS
Cancer therapy (excl. chemotherapy and radiation therapy)Predictive and prognostic markers
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (3)

|Mar 04, 2018
Addition of bevacizumab to gemcitabine for platinum-resistant recurrent ovarian cancer: a retrospective analysis.

Kazuki Takasaki, Morikazu Miyamoto, Masashi Takano

|Nov 24, 2017
Ovarian serous carcinomas acquire cisplatin resistance and increased invasion through downregulation of the high-temperature-required protein A2 (HtrA2), following repeated treatment with cisplatin.

Hiroaki Soyama, Morikazu Miyamoto, Masashi Takano

|Nov 11, 2017
Efficacy of combination chemotherapy using irinotecan and nedaplatin for patients with recurrent and refractory endometrial carcinomas: preliminary analysis and literature review.

Morikazu Miyamoto, Masashi Takano, Mika Kuwahara

Pageof 1

Frequent Collaborators

3 joint publications

Morikazu Miyamoto

3 joint publications

Masashi Takano

3 joint publications

Hiroaki Soyama

3 joint publications

Kento Kato